Cardiff Oncology, Inc.
CRDF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $137,771 | $209,557 | $208,885 | $206,801 |
| - Cash | $10,135 | $10,784 | $24,095 | $51,470 |
| + Debt | $1,010 | $1,185 | $1,356 | $1,523 |
| Enterprise Value | $128,646 | $199,958 | $186,146 | $156,854 |
| Revenue | $120 | $121 | $109 | $151 |
| % Growth | -0.8% | 11% | -27.8% | – |
| Gross Profit | $120 | -$11,459 | $109 | $151 |
| % Margin | 100% | -9,470.2% | 100% | 100% |
| EBITDA | -$10,764 | -$14,683 | -$14,154 | -$12,476 |
| % Margin | -8,970% | -12,134.7% | -12,985.3% | -8,262.3% |
| Net Income | -$11,258 | -$13,943 | -$13,434 | -$11,787 |
| % Margin | -9,381.7% | -11,523.1% | -12,324.8% | -7,806% |
| EPS Diluted | -0.17 | -0.21 | -0.28 | -0.25 |
| % Growth | 19% | 25% | -12% | – |
| Operating Cash Flow | -$10,834 | -$8,328 | -$12,794 | -$10,267 |
| Capital Expenditures | -$18 | -$26 | $0 | $0 |
| Free Cash Flow | -$10,852 | -$8,354 | -$12,794 | -$10,267 |